Abstract

Streptococcus pyogenes causes a variety of diseases ranging from mild diseases to severe invasive infections which result in significant morbidity and mortality. This study focuses on the antibiotic resistance of S. pyogenes and their interaction with cysteine protease. Around 36 beta-hemolytic isolates were collected from the clinical lab, of which seven isolates (19.4%) were identified as Streptococcus pyogenes. One of the seven isolates was collected from a urinary tract infection, which was identified by antibody agglutination and MALTI-TOF-MS, and it is designated as S. pyogenes NBMKU12. Around 8.3 to 66.6 % of the isolates were found to be resistant to one or more antimicrobial agents, especially, penicillin-G resistance was exhibited by 29.1% of the isolates. In the NBMKU12 isolate, the beta lactem (TEM) gene was detected among the 13 antibiotic genes for which it was tested. Furthermore, when analysis for presence of 13 virulence genes were carried out in NBMKU12 isolate, only speJ and speB were detected. The speB (streptococcal pyrogenic exotoxin B) encoding cysteine protease gene was cloned. This was followed by performing DNA sequencing to understand the putative cysteine protease interaction with antibiotics, inhibitors, and substrate. The speB gene consists of 1197 nucleotides and encodes a protein with multiple domains, including a signal peptide (aa 1–22), an inhibitor region (aa 27–156), and a catalytic cysteine domain (aa 160–367). The signal peptide cleavage site is predicted between Ala22 and Asn23. The putative 398 amino acid residues were found to have a theoretical pI of 8.76 and a molecular mass of 43,204.36 Da. The tested culture supernatants of NBMKU12 isolate exhibited the proteolytic activity against casein, papaya and pineapple used as substrates. The proteolytic activity suggests the expression of speB gene. Molecular docking analysis of cysteine protease showed that erythromycin (bond length 2.41 Å), followed by chloramphenicol (2.51 Å), exhibited a strong interaction; while penicillin-G (3.24 Å) exhibited a weak interaction, and this factor could be considered as a cause for penicillin-G resistance. The present study contributes to a better understanding of speB gene encoding cysteine protease, antibiotic resistance, and their interaction in the isolate, S. pyogenes NBMKU12. The antibiotics and cysteine protease interaction study confirms the resistance or sensitivity of S. pyogenes. Hence, it could be hypothesized that the isolate NBMKU12 is resistant to most of the tested antibiotics, and this resistance might be a cause for mutation.

Highlights

  • Proteases, the Cys residue acts as the nucleophile agent and the His residue acts as the proton shuttling residue

  • Keeping the important development of streptococcal pyogenes, and 1 isolate of NBMKU12 collected from a patient resistance in mind, we have studied the collection of human with urinary tract infection (UTI), were used in this study

  • This strain was labeled as Streptococcus pyogenes NBMKU12

Read more

Summary

Introduction

Proteases, the Cys residue acts as the nucleophile agent and the His residue acts as the proton shuttling residue Streptococcus pyogenes (Group A Streptococci) is the most and Menard, 1994). Cysteine proteases are responsible for widespread pathogenic bacteria that infects children and several biological processes, including degradation of peptides adolescents (Brook and Dohar, 2006). It causes a wide range and proteins (Grzonka et al, 2001). S. pyogenes causes extensive addition, the cysteine protease has the ability to cleave host cutaneous infections ranging from superficial cellulitis to severe cellulitis, and even life-threatening pyoderma (Sumitomo et al, 2018). Group A streptococci (GAS) phage-associated pyrogenic exotoxins or superantigens (Jing et al, 2006) have been shown to. E Most of the S. pyogenes strains are susceptible to penicillin (Bassetti et al, 2000), and penicillin is universally recommended for treatment of S. pyogenes infections

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.